Illumina Fact Sheet

Corporate Fact Sheet

About Illumina

Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine. With rapid advances in technology taking place, it is mission-critical to offer solutions that are not only innovative, but flexible, and scalable, with industry-leading support and service.

We strive to meet this challenge by placing a high value on collaborative interactions, rapid delivery of solutions, and meeting the needs of our customers.

Our customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.

The Illumina vision

Illumina is a global company with a vision to be the leading provider of integrated solutions that advance the understanding of genetics and health. Our goal is to improve human health by enabling our customers to accelerate the collection, analysis, and application of biological information.

Leading-edge products and services

Illumina has developed a comprehensive line of products that address the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. Our broad portfolio of leading-edge sequencing and array-based solutions address a range of genomic complexity and throughput, enabling researchers to select the best solution for their scientific challenge.

Instruments

  • NovaSeq Sequencing Systems
  • HiSeq X Sequencing Systems
  • HiSeq Sequencing Systems
  • NextSeq Sequencing Systems
  • MiSeq Sequencing System
  • MiSeqDx Sequencing System
  • MiSeq FGx Forensic Genomics System
  • MiniSeq Sequencing System
  • HiScan Array Scanner
  • iScan Array Scanner

Assays

  • TruSeq, TruSight, and Nextera technologies
  • Sequencing by synthesis chemistry
  • Infinium genotyping and methylation assays

Quick Facts

  • Website:
    www.illumina.com
  • Ticker symbol:
    ILMN
  • Headquarters:
    San Diego, California, USA
  • Number of employees:
    5,500+ globally
  • 2016 revenue:
    $2.4 Billion USD

Commercial offices

  • San Diego, CA
  • San Francisco, CA
  • Madison, WI
  • Sao Paulo, Brazil
  • Cambridge, UK
  • Eindhoven, Netherlands
  • Beijing, China
  • Shanghai, China
  • Singapore
  • Osaka, Japan
  • Tokyo, Japan
  • Melbourne, Australia

Illumina Management Team